📌 Key Takeaways
- • Foreign patient numbers in South Korea are rapidly recovering after COVID-19, with aesthetic medicine becoming one of the key drivers of medical tourism
- Leading Korean aesthetic device companies Classys, Lutronic, and Jeisys are expanding exports to global markets
- The Korean government is reviving discussions on legalizing telemedicine
These developments are not isolated news events.
Instead, they highlight a broader structural shift in South Korea’s healthcare industry — expanding across three areas:patients (medical tourism), devices (exports), and digital healthcare (policy).
South Korea’s healthcare industry is expanding on multiple fronts.
Foreign patient numbers are recovering rapidly as medical tourism rebounds after the COVID-19 pandemic. At the same time, Korean aesthetic medical device companies are strengthening their global presence, while the government is reopening discussions on telemedicine policy.
Taken together, these developments suggest that South Korea’s healthcare industry is evolving through three interconnected drivers — patients, medical devices, and digital healthcare.
This structural expansion is drawing attention from the global aesthetic medicine industry, as it illustrates how aesthetic medicine can function not only as a medical service, but also as part of a broader healthcare ecosystem.
INDEX
- Medical tourism rebounds in South Korea — aesthetic medicine leads foreign patient demand
- Korean aesthetic device companies expand globally
- Telemedicine debate resurfaces — potential implications for aesthetic medicine
- South Korea’s healthcare industry expanding in three directions
- EDITOR’S POINT | Why South Korea is often called a “global aesthetic medicine hub”
- Summary
Medical tourism rebounds in South Korea — aesthetic medicine leads foreign patient demand
According to the Korea Health Industry Development Institute (KHIDI),
the number of foreign patients visiting South Korea has been recovering rapidly following the COVID-19 pandemic.
Key areas of demand include:
• Plastic surgery
• Dermatology
• Health checkups
Major patient source countries include:
• Japan
• China
• Thailand
• United States
Aesthetic medicine has long been one of the primary motivations for medical tourism to South Korea, meaning the recovery in foreign patients is closely tied to the rebound of the aesthetic medicine market.
In effect, aesthetic medicine in Korea functions as a core component of its medical tourism industry.
Korean aesthetic device companies expand globally
At the same time, Korean aesthetic medical device companies are strengthening their presence in the global market.
Representative companies include:
• Classys
• Lutronic
• Jeisys
These firms manufacture technologies such as:
• laser devices
• HIFU systems
• RF (radiofrequency) devices
Exports are expanding particularly into:
• the United States
• Europe
• the Middle East
South Korea is now considered one of the leading exporters of aesthetic medical devices globally.
This indicates that aesthetic medicine in Korea is no longer only a service industry, but also an important medical technology sector.
Telemedicine debate resurfaces — potential implications for aesthetic medicine
South Korea is also revisiting discussions on legalizing telemedicine.
Historically, remote medical care has been largely restricted in the country.
However, discussions are resurfacing due to:
• population aging
• healthcare accessibility
• advances in digital health technology
While aesthetic medicine is not the primary focus of this policy debate,
expanded telemedicine could influence related fields such as:
• weight management medicine
• dermatology
• medical consultations
The expansion of digital healthcare could therefore reshape parts of the aesthetic medicine ecosystem.
South Korea’s healthcare industry expanding in three directions
Taken together, these developments suggest that South Korea’s healthcare industry is expanding across three dimensions:
1️⃣ Patients — medical tourism
2️⃣ Devices — global medical device exports
3️⃣ Digital healthcare — policy and telemedicine
In other words, South Korea is simultaneously:
• attracting international patients
• exporting medical technologies
• digitalizing healthcare systems
This combination is strengthening the global competitiveness of the country’s healthcare industry.
EDITOR’S POINT | Why South Korea is often called a “global aesthetic medicine hub”
South Korea’s aesthetic medicine sector is not simply a private medical service market.
It operates within a broader national healthcare ecosystem that includes:
• medical tourism
• medical device manufacturing
• digital healthcare development
Today, aesthetic medicine intersects with multiple industries:
healthcare, tourism, manufacturing, and digital technology.
South Korea’s model demonstrates how aesthetic medicine can evolve into a strategic national healthcare industry.
Summary
• Foreign patient numbers in South Korea are recovering rapidly
• Korean aesthetic device companies are expanding global exports
• Telemedicine policy discussions are accelerating again
Together, these trends illustrate the structural expansion of South Korea’s healthcare industry.
Sources
Ministry of Health and Welfare (Republic of Korea)
Government authority responsible for healthcare policy in South Korea. Publishes data and policy reports on the country’s healthcare industry and medical tourism, including statistics on foreign patients.
Korea Biomedical Review
Industry media covering South Korea’s medical and biotechnology sectors. Reported on the global expansion of Korean aesthetic medical device companies such as Classys, Lutronic, and Jeisys.
U.S. International Trade Administration (U.S. Department of Commerce)
Market analysis reports on South Korea’s healthcare industry.
In 2025, the South Korean National Assembly passed amendments to the Medical Service Act, reflecting ongoing policy developments related to healthcare services and telemedicine.
NERO’s Mission
NERO reports on global developments in aesthetic medicine
through the lens of structure, ethics, and long-term consequence.
Rather than amplifying surface-level trends,
we examine how medical practices are regulated, commercialised, and normalised —
and what is reshaped when innovation moves faster than existing frameworks.
As aesthetic medicine expands beyond traditional clinical boundaries,
NERO focuses on the grey zones where definitions blur, responsibilities shift,
and medical decision-making becomes increasingly complex.
In an era of accelerating innovation,
NERO remains committed to transparency, critical scrutiny,
and responsible reporting —
so readers can understand not only what is new,
but what deserves closer examination before it becomes standard practice.
